Intchains Group
ICG
Ebang International
EBON
IREN Ltd
IREN
FRMO CORP
FRMO
Mawson Infrastructure
MIGI
US Stock MarketDetailed Quotes
SCNI Scinai Immunotherapeutics
- 3.754
- -0.016-0.42%
Trading Jan 7 11:18 ET
3.20MMarket Cap1.56P/E (TTM)
3.820High3.754Low4.81KVolume3.809Open3.770Pre Close18.25KTurnover0.69%Turnover RatioLossP/E (Static)853.00KShares8.92052wk High0.73P/B2.63MFloat Cap2.23052wk Low--Dividend TTM700.47KShs Float6199.990Historical High--Div YieldTTM1.73%Amplitude2.230Historical Low3.792Avg Price1Lot Size
Scinai Immunotherapeutics Key Stats
EPS
According to the latest financial report of Scinai Immunotherapeutics, the latest earnings per share (TTM) for the company is 8.40. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Scinai Immunotherapeutics's free cash flow? The latest report shows it as -2.04M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Scinai Immunotherapeutics shows that the company's current ratio is 1.16, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Scinai Immunotherapeutics, the quick ratio is 1.06, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Scinai Immunotherapeutics? The latest ROE figure is -1.18K%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Scinai Immunotherapeutics, the total asset return on investment (ROA) is 77.12%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Scinai Immunotherapeutics's latest financial report to see how their gross margin is doing - currently at -148.21%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Scinai Immunotherapeutics, the net profit margin is 6.22K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.